Clinical Trials on Diffus aksonal skade
Total 2103 results
-
Chongqing University Cancer HospitalRecruitingDiffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedChina
-
The Affiliated Hospital of Qingdao UniversityNot yet recruitingDiffuse Large B Cell Lymphoma
-
Antengene CorporationRecruitingDiffuse Large B-cell Lymphoma | Indolent Non-Hodgkin LymphomaChina
-
Peking Union Medical College HospitalRecruitingDiffuse Large B Cell Lymphoma | Central Nervous System LymphomaChina
-
Centre Hospitalier Universitaire, AmiensInstitut Bergonié; Centre Henri Becquerel; Saint-Louis Hospital, Paris, France; Henri Mondor University Hospital and other collaboratorsRecruitingChemotherapy | Elderly | Diffuse Large B-Cell Lymphoma (DLBCL), NosFrance
-
Shanghai Ming Ju Biotechnology Co., Ltd.RecruitingLymphoma, Non-Hodgkin | Follicular Lymphoma | Diffuse Large B Cell LymphomaChina
-
Otsuka Pharmaceutical Co., Ltd.Active, not recruitingRelapsed or Refractory Diffuse Large B-cell LymphomaJapan
-
Karyopharm Therapeutics IncSuspendedRelapsed or Refractory Diffuse Large B-Cell LymphomaUnited States
-
Second Affiliated Hospital of Soochow UniversityEnrolling by invitationDiffuse Large B-cell LymphomaChina
-
Bristol-Myers SquibbCompletedLymphoma. Non-HodgkinGermany, Italy, United States, Spain, Netherlands, Australia, United Kingdom, Belgium, France, Canada, Sweden, Singapore
-
Carevive Systems, Inc.CompletedFollicular Lymphoma | Diffuse Large B Cell LymphomaUnited States
-
The Lymphoma Academic Research OrganisationCompletedNon Previously Treated CD20+ Diffuse Large B-cell LymphomaBelgium, France
-
Korea Cancer Center HospitalUnknownRelapsed or Refractory Diffuse Large B Cell LymphomaKorea, Republic of
-
Celgene CorporationTerminatedDiffuse Large B-cell LymphomaUnited States, Canada, Australia
-
Novartis PharmaceuticalsNot yet recruitingDiffuse Cutaneous Systemic Sclerosis
-
AmgenTerminatedDiffuse Cutaneous Systemic SclerosisUnited States
-
Assistance Publique - Hôpitaux de ParisActive, not recruitingHereditary Diffuse Gastric CancerFrance
-
Talaris Therapeutics Inc.WithdrawnDiffuse Cutaneous Systemic SclerosisUnited States
-
Lawson Health Research InstituteSeagen Inc.CompletedDiffuse Cutaneous Systemic SclerosisCanada
-
Corbus Pharmaceuticals Inc.TerminatedDiffuse Cutaneous Systemic SclerosisUnited States
-
Corbus Pharmaceuticals Inc.TerminatedDiffuse Cutaneous Systemic SclerosisUnited States, Switzerland, Korea, Republic of, Australia, Netherlands, Israel, United Kingdom, Germany, Japan, Spain, Poland, Canada
-
Inventiva PharmaCompletedScleroderma, Diffuse | Diffuse Cutaneous Systemic SclerosisUnited Kingdom, France, Spain, Switzerland, Italy, Slovenia, Netherlands, Germany, Bulgaria, Poland
-
The First Affiliated Hospital of Xiamen UniversityThe First Affiliated Hospital with Nanjing Medical University; Sun Yat-sen... and other collaboratorsRecruitingFollicular Lymphoma | DLBCL - Diffuse Large B Cell LymphomaChina
-
Universität des SaarlandesAstraZeneca; University of Leipzig; Wuerzburg University Hospital; University Hospital... and other collaboratorsRecruitingDiffuse Large B Cell Lymphoma | Large B-cell LymphomaGermany
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingDiffuse Large B-cell Lymphoma (DLBCL) | Non Hodgkin Lymphoma (NHL)United States
-
Kymera Therapeutics, Inc.SuspendedNon Hodgkin Lymphoma | Diffuse Large B Cell Lymphoma | DLBCL | MYD88 Gene MutationUnited States, United Kingdom
-
Institut Claudius RegaudAstraZenecaActive, not recruitingDiffuse Large B-cell LymphomaFrance
-
Seagen Inc.TerminatedFollicular B-cell Non-Hodgkin's Lymphoma | Diffuse Large B-cell Lymphoma RefractoryUnited States, Italy, Spain, United Kingdom, Czechia, Poland, France
-
Millennium Pharmaceuticals, Inc.CompletedNon-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL)United States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); AstraZeneca; Juno Therapeutics, Inc.; MedImmune...TerminatedRecurrent Diffuse Large B-Cell Lymphoma | Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Refractory High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Diffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedUnited States
-
Gruppo Italiano Malattie EMatologiche dell'AdultoRecruitingDLBCL - Diffuse Large B Cell LymphomaItaly
-
Fudan UniversityRecruiting
-
Second Affiliated Hospital, School of Medicine,...Recruiting
-
Herlev HospitalWeill Medical College of Cornell UniversityRecruitingDiffuse Large B Cell Lymphoma | Central Nervous System MetastasisDenmark
-
University of ChicagoMerck Sharp & Dohme LLCRecruitingLymphoma | Lymphoma, B-Cell | B Cell Lymphoma | Diffuse Large B Cell Lymphoma | High-grade B-cell LymphomaUnited States
-
Hrain Biotechnology Co., Ltd.Shanghai Zhongshan HospitalRecruitingFollicular Lymphoma | Diffuse Large B-cell Lymphoma | CD19-positiveChina
-
Curis, Inc.CompletedRelapsed and/or Refractory Diffuse Large B-cell Lymphoma Including With Myc AlterationsUnited States, Spain
-
The Netherlands Cancer InstituteDutch Cancer SocietyCompletedHodgkin Lymphoma | Diffuse Large B Cell LymphomaNetherlands
-
Janssen Research & Development, LLCTerminatedLymphoma, Follicular | Lymphoma, Large B-Cell, Diffuse | Lymphoma, Mantle-CellUnited States, Australia, France, Belgium, Turkey, Netherlands, Korea, Republic of
-
AmgenEnrolling by invitationDiffuse Cutaneous Systemic Sclerosis | Sclerosis, SystemicGermany, Spain, Korea, Republic of, Japan, Mexico, Argentina, Greece, United States, Austria, France, Israel, Poland, United Kingdom
-
National Institute of Allergy and Infectious Diseases...PPD; Rho Federal Systems Division, Inc.; Immune Tolerance Network (ITN); Seagen...CompletedDiffuse Cutaneous Systemic Sclerosis | Scleroderma | dcSScUnited States
-
AmgenRecruitingDiffuse Cutaneous Systemic Sclerosis | Sclerosis, SystemicUnited States, Korea, Republic of, Germany, Spain, Italy, Israel, Japan, Serbia, Argentina, Greece, Mexico, Poland, Chile, Austria, France, Portugal, Romania, Switzerland, United Kingdom
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Primary Mediastinal Large B-Cell Lymphoma | Refractory Primary Mediastinal Large B-Cell LymphomaUnited States
-
Nektar TherapeuticsRecruitingNon-Hodgkin Lymphoma | Relapsed/Refractory Diffuse Large B-cell LymphomaUnited States
-
SanofiMerck Sharp & Dohme LLCActive, not recruitingDiffuse Large B-cell Lymphoma | Classic Hodgkin LymphomaChile, Spain, Argentina
-
Grupo Español de Linfomas y Transplante Autólogo...Completed
-
ADC Therapeutics S.A.No longer availableRelapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)
-
Novartis PharmaceuticalsCompletedCD79 Mutant or ABC-subtype Diffuse Large B-Cell LymphomaTaiwan, Italy, Netherlands, Hong Kong, Germany, United States, Korea, Republic of, France
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedHematopoietic and Lymphoid Cell Neoplasm | Recurrent Diffuse Large B-Cell Lymphoma | Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Recurrent High Grade B-Cell Lymphoma | Recurrent... and other conditionsUnited States
-
AIDS Malignancy ConsortiumNational Cancer Institute (NCI); University of Arkansas; The Emmes Company, LLCCompletedAIDS-related Peripheral/Systemic Lymphoma | AIDS-related Diffuse Large Cell Lymphoma | AIDS-related Diffuse Mixed Cell Lymphoma | AIDS-related Diffuse Small Cleaved Cell Lymphoma | AIDS-related Immunoblastic Large Cell Lymphoma | AIDS-related Lymphoblastic Lymphoma | AIDS-related Small Noncleaved... and other conditionsZimbabwe, Kenya